These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18005736)

  • 1. Influenza A virus PB1-F2: a small protein with a big punch.
    Conenello GM; Palese P
    Cell Host Microbe; 2007 Oct; 2(4):207-9. PubMed ID: 18005736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice.
    Zamarin D; Ortigoza MB; Palese P
    J Virol; 2006 Aug; 80(16):7976-83. PubMed ID: 16873254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PB1-F2 Protein Does Not Impact the Virulence of Triple-Reassortant H3N2 Swine Influenza Virus in Pigs but Alters Pathogenicity and Transmission in Turkeys.
    Deventhiran J; Kumar SR; Raghunath S; Leroith T; Elankumaran S
    J Virol; 2016 Jan; 90(1):222-31. PubMed ID: 26468540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.
    McAuley JL; Hornung F; Boyd KL; Smith AM; McKeon R; Bennink J; Yewdell JW; McCullers JA
    Cell Host Microbe; 2007 Oct; 2(4):240-9. PubMed ID: 18005742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and Virulence of Influenza A Virus Protein PB1-F2.
    Kamal RP; Alymova IV; York IA
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the PA-X and PB1-F2 Proteins on the Virulence of the 2009 Pandemic H1N1 Influenza A Virus in Mice.
    Ma J; Li S; Li K; Wang X; Li S
    Front Cell Infect Microbiol; 2019; 9():315. PubMed ID: 31552197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein.
    Varga ZT; Ramos I; Hai R; Schmolke M; García-Sastre A; Fernandez-Sesma A; Palese P
    PLoS Pathog; 2011 Jun; 7(6):e1002067. PubMed ID: 21695240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PB1-F2 on the pathogenicity of H1N1 swine influenza virus in mice and pigs.
    Lee J; Henningson J; Ma J; Duff M; Lang Y; Li Y; Li Y; Nagy A; Sunwoo S; Bawa B; Yang J; Bai D; Richt JA; Ma W
    J Gen Virol; 2017 Jan; 98(1):31-42. PubMed ID: 28008819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice.
    Kamal RP; Kumar A; Davis CT; Tzeng WP; Nguyen T; Donis RO; Katz JM; York IA
    J Virol; 2015 Jun; 89(11):5835-46. PubMed ID: 25787281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.
    Alymova IV; York IA; McCullers JA
    PLoS One; 2014; 9(11):e111603. PubMed ID: 25368997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection.
    Alymova IV; Samarasinghe A; Vogel P; Green AM; Weinlich R; McCullers JA
    J Virol; 2014 Jan; 88(1):503-15. PubMed ID: 24173220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses.
    Alymova IV; McCullers JA; Kamal RP; Vogel P; Green AM; Gansebom S; York IA
    Sci Rep; 2018 May; 8(1):7474. PubMed ID: 29749408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral PB1-F2 and host IFN-γ guide ILC2 and T cell activity during influenza virus infection.
    Barman TK; Huber VC; Bonin JL; Califano D; Salmon SL; McKenzie ANJ; Metzger DW
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35169077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages.
    Kalantar K; Farzaneh Z; Gholijani N; Hosseini SY; Bani Hasan E
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):74-82. PubMed ID: 32534514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influenza Virus Protein PB1-F2 Increases Viral Pathogenesis through Neutrophil Recruitment and NK Cells Inhibition.
    Vidy A; Maisonnasse P; Da Costa B; Delmas B; Chevalier C; Le Goffic R
    PLoS One; 2016; 11(10):e0165361. PubMed ID: 27798704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection.
    Kosai K; Seki M; Tanaka A; Morinaga Y; Imamura Y; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Tomono K; Kohno S
    Jpn J Infect Dis; 2011; 64(6):451-7. PubMed ID: 22116322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics.
    Smith AM; Adler FR; McAuley JL; Gutenkunst RN; Ribeiro RM; McCullers JA; Perelson AS
    PLoS Comput Biol; 2011 Feb; 7(2):e1001081. PubMed ID: 21379324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection.
    McAuley J; Deng YM; Gilbertson B; Mackenzie-Kludas C; Barr I; Brown L
    Virol J; 2017 Aug; 14(1):162. PubMed ID: 28830486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the host specificity of PB1-F2-associated virulence.
    Mettier J; Marc D; Sedano L; Da Costa B; Chevalier C; Le Goffic R
    Virulence; 2021 Dec; 12(1):1647-1660. PubMed ID: 34125653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza.
    Park ES; Byun YH; Park S; Jang YH; Han WR; Won J; Cho KC; Kim DH; Lee AR; Shin GC; Park YK; Kang HS; Sim H; Ha YN; Jae B; Son A; Kim P; Yu J; Lee HM; Kwon SB; Kim KP; Lee SH; Park YM; Seong BL; Kim KH
    EMBO J; 2019 May; 38(10):. PubMed ID: 30979777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.